{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:57:58Z","timestamp":1794542278011,"version":"4.9.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1365-2133.2009.09091.x","type":"journal-article","created":{"date-parts":[[2009,3,9]],"date-time":"2009-03-09T14:48:04Z","timestamp":1236610084000},"page":"134-139","source":"Crossref","is-referenced-by-count":143,"title":["Willingness-to-pay and quality of life in patients with vitiligo"],"prefix":"10.1093","volume":"161","author":[{"given":"M.A.","family":"Radtke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gajur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Langenbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Augustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB1","doi-asserted-by":"crossref","DOI":"10.1002\/9780470760116","volume-title":"Vitiligo","author":"Hahn","year":"2000"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/978-1-4615-9272-3","volume-title":"Vitiligo and other Hypomelanoses of Hair and Skin","author":"Ortonne","year":"1983"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB3","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1365-2133.2005.06456.x","article-title":"Effect of vitiligo on self-reported health-related quality of life","volume":"152","author":"Ongenae","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0151-9638(07)91814-1","article-title":"Vitiligo and quality of life: a case control study","volume":"134","author":"Belhadjali","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2008.08678.x","article-title":"Identification of categories at risk for high quality of life impairment in patients with vitiligo","volume":"159","author":"Sampogna","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB6","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/archderm.144.8.1062","article-title":"Characteristics of patients with universal vitiligo and health-related quality of life","volume":"144","author":"Linthorst Homan","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S1550-8579(06)80201-9","article-title":"Quality of life with vitiligo: comparison of male and female Muslim patients in Iran","volume":"3","author":"Borimnejad","year":"2006","journal-title":"Gend Med"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000128992","article-title":"Benefit evaluation in vitiligo treatment: development and validation of a patient-defined outcome questionnaire","volume":"217","author":"Augustin","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0277-9536(85)90021-8","article-title":"Skin disease and handicap: an analysis of the impact of skin conditions","volume":"20","author":"Jowett","year":"1985","journal-title":"Soc Sci Med"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0163-8343(79)90081-1","article-title":"Psychological reaction to chronic skin disorders: a study of patients with vitiligo","volume":"1","author":"Porter","year":"1979","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1365-4632.2004.02059.x","article-title":"What patients with vitiligo believe about their condition","volume":"43","author":"Firooz","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0190-9622(90)70028-G","article-title":"The effect of vitiligo on sexual relationships","volume":"22","author":"Porter","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB14","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archderm.1978.01640210075025","article-title":"Personal responses to vitiligo: the importance of the patient-physician interaction","volume":"114","author":"Porter","year":"1978","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1046\/j.1468-3083.2002.00590.x","article-title":"Psychiatric morbidity in vitiligo: prevalence and correlates in India","volume":"16","author":"Mattoo","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol - a new facility for the measurement of health related quality of life","volume":"16","author":"EuroQol","year":"1990","journal-title":"Health Policy"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB18","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/0272989X9601600314","article-title":"When do the \u2018dollars\u2019 make sense? Toward a conceptual framework for contingent valuation studies in health care","volume":"16","author":"O\u2019Brien","year":"1996","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2133.2007.08354.x","article-title":"Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study","volume":"158","author":"Schmitt","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB20","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2133.2006.07740.x","article-title":"Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis","volume":"156","author":"Cham","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB21","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1365-2133.2003.05156.x","article-title":"Willingness-to-pay and time-trade-off: sensitive to changes of quality of life in psoriasis patients?","volume":"148","author":"Schiffner","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-2133.2002.04613.x","article-title":"Willingness to pay and time trade-off: useful utility indicators for the assessment of quality of life and patient satisfaction in patients with port wine stains","volume":"146","author":"Schiffner","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1468-3083.2000.00034.x","article-title":"Patient attitudes to topical antipsoriatic treatment with calcipotriol and dithranol","volume":"14","author":"Poyner","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB24","first-page":"1","article-title":"Policy decision making and outcomes research in drug utilization","volume":"1","author":"Rychlik","year":"2005","journal-title":"Z Gesundheitswiss\/J Public Health"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB25","volume-title":"GMS Health Technol Assess 1: Doc09, 2005","author":"Zentner"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB26","volume-title":"Fragebogen zur Bew\u00e4ltigung von Hautkrankheiten (FBH). Handanweisung","author":"Stangier","year":"1996"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s001050051056","article-title":"Quality of life in skin diseases: methodological and practical comparison of different quality of life questionnaires in psoriasis and atopic dermatitis","volume":"50","author":"Augustin","year":"1999","journal-title":"Hautarzt"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0272989X8400400207","article-title":"Feasibility of willingness-to-pay in arthritis","volume":"4","author":"Thompson","year":"1984","journal-title":"Med Decis Making"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB29","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000119415","article-title":"Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter prospective cross-sectional study in Germany","volume":"216","author":"Augustin","year":"2008","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000246657","article-title":"Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism","volume":"190","author":"Salzer","year":"1995","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB31","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1365-2230.1996.tb00116.x","article-title":"Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers","volume":"21","author":"Kent","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02154.x","article-title":"Narrow-band UVB 312\u2003nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo","volume":"44","author":"Hartmann","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2133.2003.05097_9.x","article-title":"Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome","volume":"148","author":"Parsad","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2133.1995.tb05019.x","article-title":"The effect of severe psoriasis on the quality of life of 369 patients","volume":"132","author":"Finlay","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00019053-200321120-00003","article-title":"Defining monetary values for quality of life improvements: an exploratory study","volume":"21","author":"Lachaine","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1365-2133.1999.03207.x","article-title":"Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema","volume":"141","author":"Lundberg","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.2007.08236.x","article-title":"Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis","volume":"158","author":"Revicki","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-4-71","article-title":"The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study","volume":"4","author":"Shikiar","year":"2006","journal-title":"Health Qual Life Outcomes"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB41","first-page":"339","article-title":"A randomized controlled clinical trial assessing the effect of betamethasone valerate 0\u00b712% foam on the short-term treatment of stasis dermatitis","volume":"4","author":"Weiss","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09091.x-BIB42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/art.20903","article-title":"Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis","volume":"53","author":"van den Hout","year":"2005","journal-title":"Arthritis Care Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09091.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09091.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:44:36Z","timestamp":1676382276000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/161\/1\/134\/6642035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09091.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}